InvestorsObserver
×
News Home

Where Will Aphria Inc (APHA) Stock Go Next After It Has Gained 8.49% in a Week?

Monday, July 27, 2020 11:39 AM | InvestorsObserver Analysts

Mentioned in this article

Where Will Aphria Inc (APHA) Stock Go Next After It Has Gained 8.49% in a Week?

The market has been neutral on Aphria Inc (APHA) stock recently. APHA gets a Neutral score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,neutral
Aphria Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on APHA!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With APHA Stock Today?

Aphria Inc (APHA) stock is trading at $5.62 as of 11:37 AM on Monday, Jul 27, a rise of $0.50, or 9.88% from the previous closing price of $5.11. The stock has traded between $5.19 and $5.67 so far today. Volume today is more active than usual. So far 6,322,701 shares have traded compared to average volume of 4,929,460 shares.

To see the top 5 stocks in the Drug Manufacturers - Specialty & Generic industry click here.

More About Aphria Inc

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not currently operate in the U.S. due to federal prohibition. The company is focusing on expanding through international cultivation and distribution into the global medical cannabis market. Aphria also offers multiple products under a portfolio of recreational cannabis brands, including Solei, RIFF, and Broken Coast.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App